Search for: "Purdue Pharma Inc." Results 81 - 100 of 152
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Feb 2012, 8:34 pm by Patent Docs
Purdue Pharma L.P. et al. v. [read post]
12 Dec 2011, 7:24 am by Matthew Huisman
A Penalty that Includes Career Death: The former top executives and general counsel of Purdue Pharma L.P. are fighting their 12-year ban on working in the health care and pharmaceutical industries. [read post]
28 Oct 2011, 4:30 am
Editors’ Note: For an outstanding article on CAFA jurisdiction and parens patriae, see “Removal of Attorney General Actions Under the Class Action Fairness Act of 2005,” BNA, Inc. [read post]
28 Oct 2011, 4:30 am
Editors’ Note: For an outstanding article on CAFA jurisdiction and parens patriae, see “Removal of Attorney General Actions Under the Class Action Fairness Act of 2005,” BNA, Inc. [read post]
20 Jul 2011, 4:04 am by Marie Louise
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
4 May 2011, 7:52 am by Tron Emptage
Brand Name Opioid Products Generic Name Trade Name Applicant/Sponsors Fentanyl Duragesic Extended Release Transdermal System Ortho McNeil Janssen Hydromorphone *Palladone Extended Release Capsules Purdue Pharma   Methadone Dolophine Tablets Roxanne Morphine Avinza® Extended Release Capsules King Pharms   Morphine Kadian® Extended Release Capsules Actavis   Morphine MS Contin Extended Release Tablets … [read post]
6 Apr 2011, 12:18 am by Marie Louise
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
27 Mar 2011, 9:28 pm by Patent Docs
Purdue Pharma L.P. et al. v. [read post]
18 Aug 2010, 12:19 am by Kelly
and industrial applicability on 7 October: Eli Lilly & Co v Human Genome Sciences Inc (IPKat) Nuvigil (Armodafinil) – US: Cephalon and Mylan Pharmaceuticals agree to drop two patents from Nuvigil patent suit (Patent Docs) OxyContin (Oxycodone) – Patent infringement complaint filed following a Paragraph IV certification: Purdue Pharma L.P. et al. v. [read post]